Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Recruitment status on the study page has been updated to indicate enrollment is closed ('No longer looking for participants'). New guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention label formatting was adjusted, with a new page revision version.
    Difference
    0.4%
    Check dated 2026-06-12T16:31:32.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page footer updated its revision number from v3.5.4 to v3.5.5, representing a small site update; no visible content changes to the study details or layout.
    Difference
    0.0%
    Check dated 2026-06-05T11:25:06.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's revision metadata.
    Difference
    0.0%
    Check dated 2026-05-15T05:42:41.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page’s revision identifier was updated from v3.5.2 to v3.5.3, reflecting a platform/version update rather than substantive study content changes.
    Difference
    0.0%
    Check dated 2026-04-24T05:51:37.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    - Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:20:29.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    UI/layout adjustments and a timestamp update are visible on the study page. No substantive data such as eligibility criteria, endpoints, enrollment, or site information appears to have changed.
    Difference
    0.0%
    Check dated 2026-04-02T14:58:25.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.